hypoxanthine has been researched along with Adenocarcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keen, JC; Melera, PW; Obajimi, O | 1 |
| Faessel, HM; Greco, WR; Rustum, YM; Slocum, HK | 1 |
| Houghton, JA; Houghton, PJ | 1 |
| Bertino, JR; Handschumacher, RE; Sobrero, AF | 1 |
| Lönn, S; Lönn, U | 1 |
5 other study(ies) available for hypoxanthine and Adenocarcinoma
| Article | Year |
|---|---|
Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence.
Topics: Adenocarcinoma; Adenosine Triphosphate; AMP-Activated Protein Kinase Kinases; Cell Line; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Epithelial Cells; Glutamates; Humans; Hypoxanthine; Male; Prostate; Prostatic Neoplasms; Protein Kinases; Purines; Pyrimidines; Signal Transduction; Tumor Suppressor Protein p53 | 2009 |
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Cell Division; Drug Resistance, Multiple; Drug Synergism; Enzyme Inhibitors; Folic Acid; Glutamates; Hematinics; Humans; Hydroxymethyl and Formyl Transferases; Hypoxanthine; Ileal Neoplasms; Peptide Synthases; Phosphoribosylglycinamide Formyltransferase; Pyrimidines; Quinazolines; Thiophenes; Thymidine; Thymidylate Synthase; Trimetrexate; Tumor Cells, Cultured | 2003 |
Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
Topics: Adenocarcinoma; Allopurinol; Animals; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Hypoxanthine; Hypoxanthines; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation, Heterologous | 1982 |
Highly selective drug combinations for human colon cancer cells resistant in vitro to 5-fluoro-2'-deoxyuridine.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Cell Line; Colonic Neoplasms; Drug Resistance; Floxuridine; Humans; Hypoxanthine; Hypoxanthines; Methotrexate; Nucleosides; Quinazolines; Thymidine | 1985 |
The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil.
Topics: Adenocarcinoma; Cell Division; Cell Survival; Cells, Cultured; Colonic Neoplasms; DNA, Neoplasm; Drug Administration Schedule; Drug Interactions; Fluorouracil; Humans; Hypoxanthine; Hypoxanthines; Methotrexate | 1986 |